Pre-Market Stock Notes (FEB 6, 2007)

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

(ABT) Abbott announces plans to initiate the world’s first drug-eluting stent clinical trial solely in women.
(ADM) Archer Daniels Midland named Patricia Woertz as Chairman.
(ALD) Allied Capital received subpoena from U.S. Attorney over phone records illegally being taken.
(ALU) Alcatel-Lucent may cut 20,000 jobs now, more than the pre-merger estimates.
(AMSC) American Superconductor says receives order from Suzlon Energy for Australian wind farm.
(AVP) Avon $0.41 EPS vs $0.38e.
(BCRX) BioCryst Pharm says EMEA grants Orphan Drug designation to it’s Fodosine for the treatment of cutaneous T-Cell lymphoma.
(CE) Celanese $0.77 EPS vs $0.58e.
(CHINA) CDC Corp puts Q$ guidance higher than expected.
(CMS) CMS Energy announces sale of ownership interests in businesses in the Middle East, Africa, and India.
(CMTL) Comtech Telecom receives $2.5M purchase order amendment for NATO Force tracking system.
(CSCO) Cisco reports earnings after the close.
(CYBX) Cyberonics depression implantable device will not get Medicare coverage.
(DRIV) Digital River announced $9.4 million charges in 8-years of options pricing, but says no officer or director engaged in any wrongdoings for personal gains.
(EMR) Emerson $0.55 EPS VS $0.53e.
(EOP) Equity Office gets raised bid by Blackstone to $55.50 per share.
(GE) GE is acquiring into the EU Water Market.
(HOKU) HOKU Scientific and Solar-Fabrik announce plan to increase volume of polysilicon supply agreement.
(HOLL) Hollywood Media acquires broadway ticketing business of Showtix.
(IMCL) ImClone Systems opts-out of development agreement with UCB to focus resources to focus on vascular growth receptor.
(ISE) International Securities Exchange $0.41 EPS vs $0.37e.
(JRC) Journal register $0.26 EPS vs $0.24e.
(MANT) ManTech Wins $80M Army contract to support global property management services.
(MHP) McGraw Hill’s S&P unit is acquiring two index fund families from Goldman Sachs.
(MOVI) Movie Gallery is refinancing its senior credit facilities.
(MTG) MGIC merging with Radian (RDN) for 0.965 shares of MTG per RDN share.
(NSM) National Semiconductor lowered guidance.
(OMTR) Omniture gets Zune optimization order from Microsoft.
(OPXA) Opexa Therapeutics announced encouraging clinical data on novel T-Cell vaccination therapy for rheumatoid arthritis.
(PLD) Prologis $1.11 EPS vs $1.07e.
(RATE) Bankrate.com $0.27 EPS vs $0.24e.
(RNWK) Real Networks is acquiring Atrativa in Brazil.
(SCRX) Sciele Pharma signs a development and marketing agreement for a Novel Combination of fenofibrate and pravastatin to treat mixed dyslipidemia.
(SOHU) Sohu.com $0.16 EPS vs $0.17e.
(STZ) Constellation Brands is buying Svedka Vodka-Mark One.
(TBIO) Transgenomic renews collaboration with Fiuotecnica S.r.l. to develop and market gene panel for cardiovascular disease.
(TM) Toyota showed 7% earnings gain.
(TWTR) Tweeter $0.08 EPS vs $0.20e; unsure if comparable but cites television category competition as reason for weakness.
(TYC) Tyco $0.45 EPS vs $0.44e.
(ULBI) Ultralife Batteries receives $4.6 mln in military battery orders.
(URBN) Urban Outfitters reports Q4 sales of $360.8M vs $358.0M consensus.
(VIAC) ViaCell has made the decision not to advance CB001 in future clinical trials.

by Jon C. Ogg

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618